Richard Spijkers

LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.

ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands.

beeOLED GmbH is a technology company based in Dresden, Germany that specializes in developing highly efficient blue emitters for OLED displays. beeOLED's technology concept is based on a single atom emitter that generates light 100%% efficiently, making it fundamentally impossible to break anything. The German company leverages the latest advances in europium chemistry and innovative organic ligands to develop highly stabilized blue eu (ii) -complexes that are air-stable and have nearly unity photoluminescence quantum yield. The company was founded in 2020 by Jan Blochwitz-Nimoth, Carsten Rothe, and Volodymyr Senkovskyy, with Jan Blochwitz-Nimoth serving as the CEO since then.

Luxexcel Group BV provides printoptical solutions for the LED lighting industry. It develops, manufactures, and markets optical solutions for the LED lighting industry. The firm offers Fresnel lenses, linear prism structures, micro optics, lens combinations, integrated-graphics, color lenses, and lens arrays. Its products are used in linear fixtures, LED arrays, recessed spotlights, recessed floor lights, table and floor lamps, and special applications. It also provides optics design, optical prototyping, small series production, and large-scale manufacturing services. The company was founded by Richard van de Vrie and Kurt Blessing in 2009 and is headquartered in Eindhoven, Netherlands.

PhoeniX BV provides solutions for micro and nano technologies. Its products include manufacturing automation, design solutions and design kits. It supports organizations worldwide to improve quality, reduce time to market and enhance research by offering highly integrated software solutions, training and customer support. The firm’s tool enables designers to automatically synthesize photonics designs, driven by fabrication information and required optical specifications. The company was founded by Arjen Bakker and Jan Bose in 2003 and is headquartered in Enschede, the Netherlands.

SolMateS BV designs and supplies industrial deposition equipment. It offers PbZrTiOx wafers, chemicals sol-etchers and sol-cleaners, ferroelectric thin film solutions, piezoelectric thin films, and piezoelectric layers. The company serves developers and industrial users; miniaturized systems uses; and microphones, ultrasound heads, and band filters applications. The company was founded by Matthijn Dekkers, Joska Broekmaat and Arjen Janssens in 2006 and is headquartered in Enschede, the Netherlands.

Parcom Capital Management BV is an independent private equity firm founded in 1982. Parcom Capital Management BV is headquartered in Amsterdam.

Encapson BV operates as a medical device technology company. It specializes in the use of polymer-based capsules for microencapsulation. The company's products include Capsol, a paclitaxol delivery method for drug eluting balloons; and Sono-coat, an echogenic coating that is applied for biopsy and anesthesiology needles, brachytherapy needles, guiding and embryo transfer catheters, and drainage catheters. Encapson was founded by Lee Ayres and Dennis Manuel Vriezema in 2005 and is headquartered in Enschede, the Netherlands.

20Med Therapeutics BV operates as a biomedical company. It focuses on the development of biodegradable materials for biomedical applications and multifunctional nanosystems for controlled drug and gene delivery. The company was founded by Johan F. J. Engbersen in 2011 and is headquartered in Enschede, the Netherlands.

AIMM Therapeutics BV develops therapeutic antibodies for the treatment of cancer and infectious diseases. Its antibody discovery platform couples proprietary knowledge of B cell immortalization with the isolation of antibodies from humans or animals. The company was founded by Donald Kalff and Hergen Spits in 2004 and is headquartered in Amsterdam, the Netherlands.

Micronit Microfluidics BV designs, develops and manufactures custom made microfluidic components based on micro- and nanotechnology. The firm’s products include droplet generators, microreactors, flow cells, micromixers, chip holders and connections, electrical impedance spectropscoy (EIS) chips and microfluidic starter kit. The company was founded by Ronny van ‘t Oever in 1999 and is headquartered in Enschede, the Netherlands.

Regenesance BV develops drugs for the treatment of neurodegenerative and immune mediated disorders. Its products include Regenemab, a monoclonal antibody for multiple indications like PNH, myasthenia gravis, amyotrophic lateral sclerosis, and multiples sclerosis. The company was founded by Valeria Ramaglia, Mikael Orum, Frank Baas and Kees Fluiter in 2009 is headquartered in Amsterdam, the Netherlands.

Corgo NV specializes in corporate consulting services. The company determines the required profiles for client’s new directors, engages a network of professional external directors, recommends suitable candidates, and refers search specialists. It was founded by Karel Plasman in 2003 and is headquartered in Brussels, Belgium.

Axelera AI BV is a Dutch company that provides advanced solutions for AI at the edge. The company's Metis AI platform is a hardware and software solution that enables computer vision applications to become more accessible, powerful, and user-friendly. The company is headquartered in the AI innovation center of the High Tech Campus in Eindhoven, Netherlands, with R&D offices in other countries and more than 130 employees in 15 countries. Axelera AI offers scalable solutions that can be easily integrated into any system, delivering scalable, flexible, GPU-like acceleration within limited budgets. The company was founded in 2019 by Cyril Vancura, Fabrizio del Maffeo, Evangelos Eleftheriou, and Fabrizio del Maffeo has been the CEO since 2019.